Kevin T. McDonagh - Concepedia

Author

Kevin T. McDonagh

Also Known As

K McDonagh, K T McDonagh, K T Mcdonagh, K. McDonagh, K. T. McDonagh, K.T. McDonagh, KEVIN McDONAGH, KEVIN T. McDONAGH, Kevin McDonagh, Kevin T McDonagh

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

University of Michigan University of Kentucky National Institutes of Health The University of Texas MD Anderson Cancer Center Mayo Clinic in Arizona

About

Kevin T. McDonagh is an author at University of Michigan specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	1.6K
2	Engineering	1	1	17
3	Health Sciences	1	1	28
4	Natural Sciences	1	1	46
5	Biomedical Engineering	1	1	17

Kevin T. McDonagh

Publications

Citations

H-Index

Page 1

	Year	Citations
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. Robert E. Donahue, Steven Kessler, David M. Bodine, The Journal of Experimental Medicine Viral ReplicationCell TherapyImmunologyHuman RetrovirusBone Marrow	1992	537
MT1-MMP–dependent neovessel formation within the confines of the three-dimensional extracellular matrix Tae‐Hwa Chun, Farideh Sabeh, Ichiro Ota, The Journal of Cell Biology	2004	341
Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Paul A. Ney, Brian P. Sorrentino, Kevin T. McDonagh, Genes & Development Tandem Ap-1-binding SitesMolecular RegulationGeneticsBlood CellCellular Physiology	1990	299
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study Richard A. Nash, Peter A. McSweeney, Leslie J. Crofford, Blood	2007	257
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma Ravi Vij, Michael Wang, Jonathan L. Kaufman, Blood	2012	254
Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis Yoshitaka Morita, Jian-Min Yang, Raj Gupta, Journal of Clinical Investigation	2001	192
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes Peter A. McSweeney, Richard A. Nash, Keith M. Sullivan, Blood	2002	184
Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. David M. Bodine, Kevin T. McDonagh, Stephen J. Brandt, Proceedings of the National Academy of Sciences Viral ReplicationDevelopmental BiologyXenotransplantationNeurovirologyImmunology	1990	182
An open‐label, single‐arm, phase 2 study of single‐agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib Ravi Vij, David S. Siegel, Sundar Jagannath, British Journal of Haematology	2012	176
Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors: A report of four cases Leslie J. Crofford, Jim C. Oates, W. Joseph McCune, Arthritis & Rheumatism	2000	153

Page 1